Tag Archives: takes

Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »

Shoppers takes page from Big Pharma, sponsors talks for doctors on medical cannabis, which it plans to sell

The part of me that lurks underneath isn’t finished grappling with this French journalist acting the tough, hard-bitten reporter The tests claim to be able to identify food sensitivities associated with headaches, lethargy, brain fog, depression and an huge array of other symptoms We concluded that practically all of western Canada, and the sizeable conservative… Read More »